Omakase Consulting

Silver Sponsor

We are the best strategic partner to lead innovative drugs from EU approval to national P&R and Market Access in Spain,specialised in oncology, orphan drugs and Advanced Therapies (ATMPs).

We offer strategic support to companies during the drugs’ full lifecycle: from the regulatory process, including the Therapeutic Positioning Report (TPR) development to P&R submission, negotiation and approval, and Market Access at regional and hospital level. We do so by collaborating with relevant stakeholders, scientific societies and patients associations to ensure a successful Pricing and Market Access for innovative drugs in Spain.

website